首页 | 本学科首页   官方微博 | 高级检索  
     

89SrCl2治疗无骨痛的多发性骨转移瘤的效果
引用本文:欧阳伟,刘金华,刘伟英. 89SrCl2治疗无骨痛的多发性骨转移瘤的效果[J]. 南方医科大学学报, 2007, 27(3): 390-391
作者姓名:欧阳伟  刘金华  刘伟英
作者单位:南方医科大学珠江医院核医学科,广东,广州,510282;南方医科大学珠江医院核医学科,广东,广州,510282;南方医科大学珠江医院核医学科,广东,广州,510282
摘    要:目的 评价89SrCl2治疗无骨痛的多发性骨转移瘤的疗效和安全性.方法 54例不伴骨痛的多发性骨转移瘤病人,首次静脉注射89SrCl2,剂量根据体质量计算为1.48~2.22MBq/kg,重复给药间隔3~6个月,给药次数为1~3次.结果 54例病人中,总有效率为74.0%,病灶直径>2 cm病人的有效率较≤2 cm病人明显为低(33.3% vs 66.6%,χ2=14.9,P<00.1).89SrCl2治疗的副作用为白细胞和血小板降低,但绝大数病人为轻度降低,且可以恢复正常,无需特别处理.结论 89SrCl2治疗无骨痛的多发性骨转移瘤有效且安全.

关 键 词:骨肿瘤  肿瘤转移  锶/放射性同位素  放射疗法
文章编号:1673-4254(2007)03-0390-02
收稿时间:2006-03-18
修稿时间:2006-03-18

Therapeutic efficacy of strontium-89-chloride for bone metastatic tumors without bone pain
OUYANG Wei,LIU Jin-hua,LIU Wei-ying. Therapeutic efficacy of strontium-89-chloride for bone metastatic tumors without bone pain[J]. Journal of Southern Medical University, 2007, 27(3): 390-391
Authors:OUYANG Wei  LIU Jin-hua  LIU Wei-ying
Affiliation:Department of Nuclear Medicine, Zhujiang Hospital, South Medical University, Guangzhou 510282, China. oyw88@ tom.com
Abstract:OBJECTIVE: To evaluate the safety and efficacy of strontium-89-chloride for management of bone metastases in patients without bone pain. METHODS: Fifty-four patients without painful bone metastases were given a single intravenous dose (1.48-2.22 MBq/kg) of strontium-89-chloride, which was repeated once or twice at the interval between 3 and 6 months. RESULTS: The total response rate was 74.0% in these, and the response rate was significantly lower in patients with focal size>2 cm than in those with focal size
Keywords:bone neoplasms   neoplasm metastasis   strontium/radioisotopes   radiotherapy
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《南方医科大学学报》浏览原始摘要信息
点击此处可从《南方医科大学学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号